T2 Biosystems logo

T2 Biosystems share price today

(TTOO)

T2 Biosystems share price is $0.41 & ₹35.18 as on 7 Jan 2025, 2.30 'hrs' IST

$0.41

Market is closed - opens 8 PM, 07 Jan 2025

View live T2 Biosystems share price in Dollar and Rupees. Guide to invest in T2 Biosystems stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in T2 Biosystems, along with analyst recommendations, forecasts, and comprehensive financials.

T2 Biosystems share price movements

  • Today's Low: $0.40
    Today's High: $0.42

    Day's Volatility :4.59%

  • 52 Weeks Low: $0.31
    52 Weeks High: $6.95

    52 Weeks Volatility :95.54%

T2 Biosystems Returns

PeriodT2 Biosystems IncIndex (Russel 2000)
3 Months
-73.89%
0.0%
6 Months
-91.53%
0.0%
1 Year
-92.79%
0.0%
3 Years
-99.98%
-19.8%

T2 Biosystems Key Statistics

in dollars & INR

Previous Close
$0.41
Open
$0.42
Today's High
$0.4204
Today's Low
$0.4011
Market Capitalization
$10.5M
Today's Volume
$839.7K
52 Week High
$6.95
52 Week Low
$0.31
Revenue TTM
$7.2M
EBITDA
$-42.1M
Earnings Per Share (EPS)
$-0.03
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-622.14%

How to invest in T2 Biosystems from India?

It is very easy for Indian residents to invest directly in T2 Biosystems from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the T2 Biosystems stock in both Indian Rupees (INR) and US Dollars (USD). Search for T2 Biosystems or TTOO on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of T2 Biosystems or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of T2 Biosystems shares which would translate to 2.093 fractional shares of T2 Biosystems as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like T2 Biosystems, in just a few clicks!

Returns in T2 Biosystems for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

T2 Biosystems investment value today

Current value as on today

₹10,428

Returns

₹89,572

(-89.57%)

Returns from T2 Biosystems Stock

₹92,794 (-92.79%)

Dollar Returns

₹3,223 (+3.22%)

Indian investors sentiment towards T2 Biosystems

17.5%

Period: Oct 8, 2024 to Jan 6, 2025. Change in 30 Days versus previous period

Investment in T2 Biosystems from India has grown in the last 30 days as on Jan 7, 2025. 17.5% more purchase transactions for T2 Biosystems in the last 30 days versus the previous period.

-5%

Period: Oct 8, 2024 to Jan 6, 2025. Change in 30 Days versus previous period

Search volume for T2 Biosystems on INDmoney from India has reduced in the last 30 days as on Jan 7, 2025. -5% less investors are searching T2 Biosystems in the last 30 days versus the previous period.

Global Institutional Holdings in T2 Biosystems

  • Armistice Capital, LLC

    6.63%

  • Vanguard Group Inc

    1.86%

  • Geode Capital Management, LLC

    0.43%

  • BlackRock Inc

    0.37%

  • State Street Corp

    0.30%

  • Susquehanna International Group, LLP

    0.22%

Analyst Recommendation on T2 Biosystems

Sell

    0%Buy

    50%Hold

    50%Sell

Based on 6 Wall street analysts offering stock ratings for T2 Biosystems(by analysts ranked 0 to 5 stars)

Based on 6 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
0
0
0
Hold
3
3
3
Sell
3
3
3

Analyst Forecast on T2 Biosystems

What analysts predicted

Upside of 1119.51%

Current:

$0.41

Target:

$5.00

Insights on T2 Biosystems

  • Price Movement

    In the last 7 days, TTOO stock has moved down by -3.5%
  • Increasing Revenue

    Revenue is up for the last 2 quarters, 1.95M → 1.98M (in $), with an average increase of 1.7% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, -8.96M → -10.11M (in $), with an average decrease of 12.9% per quarter
  • TTOO vs A (1 yr)

    In the last 1 year, Agilent Technologies Inc. has given 3.9% return, outperforming this stock by 96.8%
  • TTOO vs A (3 yr)

    In the last 3 years, T2 Biosystems Inc has experienced a drawdown of -100.0%, however Agilent Technologies Inc. resisted the overall trend and outperformed by 91.0%
  • Price to Sales

    ForTTOO every $1 of sales, investors are willing to pay $0.4, whereas for Agilent Technologies Inc., the investors are paying $6.1 for every $1 of sales.

T2 Biosystems Financials in INR & Dollars

FY18Y/Y Change
Revenue
$10.5M
↑ 125.03%
Net Income
$-51.2M
↓ 18.06%
Net Profit Margin
-487.17%
↑ 850.76%
FY19Y/Y Change
Revenue
$8.3M
↓ 20.62%
Net Income
$-63.1M
↑ 23.38%
Net Profit Margin
-757.19%
↓ 270.02%
FY20Y/Y Change
Revenue
$18.1M
↑ 117.52%
Net Income
$-49.2M
↓ 22.03%
Net Profit Margin
-271.42%
↑ 485.77%
FY21Y/Y Change
Revenue
$28.1M
↑ 54.76%
Net Income
$-53.5M
↑ 8.71%
Net Profit Margin
-190.66%
↑ 80.76%
FY22Y/Y Change
Revenue
$22.3M
↓ 20.5%
Net Income
$-63.4M
↑ 18.46%
Net Profit Margin
-284.11%
↓ 93.45%
FY23Y/Y Change
Revenue
$7.2M
↓ 67.75%
Net Income
$-50.1M
↓ 20.98%
Net Profit Margin
-696.19%
↓ 412.08%
Q2 FY23Q/Q Change
Revenue
$2.0M
↓ 5.49%
Net Income
$-6.3M
↓ 68.33%
Net Profit Margin
-323.17%
↑ 641.17%
Q3 FY23Q/Q Change
Revenue
$1.5M
↓ 25.05%
Net Income
$-15.4M
↑ 143.03%
Net Profit Margin
-1.0K%
↓ 724.72%
Q4 FY23Q/Q Change
Revenue
$1.7M
↑ 14.06%
Net Income
$-10.3M
↓ 32.97%
Net Profit Margin
-615.84%
↑ 432.05%
Q1 FY24Q/Q Change
Revenue
$2.1M
↑ 22.75%
Net Income
$-13.5M
↑ 30.89%
Net Profit Margin
-656.67%
↓ 40.83%
Q2 FY24Q/Q Change
Revenue
$2.0M
↓ 5.29%
Net Income
$-9.0M
↓ 33.77%
Net Profit Margin
-459.17%
↑ 197.5%
Q3 FY24Q/Q Change
Revenue
$2.0M
↑ 1.69%
Net Income
$-10.1M
↑ 12.88%
Net Profit Margin
-509.67%
↓ 50.5%
FY18Y/Y Change
Profit
$-4.9M
↓ 33.39%
FY19Y/Y Change
Profit
$-8.4M
↑ 71.86%
FY20Y/Y Change
Profit
$-3.2M
↓ 62.62%
FY21Y/Y Change
Profit
$7.4M
↓ 333.49%
FY22Y/Y Change
Profit
$1.2M
↓ 84.15%
FY23Y/Y Change
Profit
$-8.2M
↓ 800.69%
Q2 FY23Q/Q Change
Profit
$-2.9M
↑ 51.54%
Q3 FY23Q/Q Change
Profit
$-2.5M
↓ 15.56%
Q4 FY23Q/Q Change
Profit
$-895.0K
↓ 63.51%
Q1 FY24Q/Q Change
Profit
$-2.1M
↑ 139.22%
Q2 FY24Q/Q Change
Profit
$-741.0K
↓ 65.39%
Q3 FY24Q/Q Change
Profit
$-2.1M
↑ 185.56%
FY18Y/Y Change
Operating Cash Flow
$-40.1M
↓ 15.88%
Investing Cash Flow
$-593.0K
↓ 76.05%
Financing Cash Flow
$49.7M
↑ 168.34%
FY19Y/Y Change
Operating Cash Flow
$-45.4M
↑ 13.01%
Investing Cash Flow
$-761.0K
↑ 28.33%
Financing Cash Flow
$6.4M
↓ 87.21%
FY20Y/Y Change
Operating Cash Flow
$-43.2M
↓ 4.73%
Investing Cash Flow
$-36.3M
↑ 4664.91%
Financing Cash Flow
$85.6M
↑ 1248.14%
FY21Y/Y Change
Operating Cash Flow
$-38.9M
↓ 10.05%
Investing Cash Flow
$24.8M
↓ 168.37%
Financing Cash Flow
$20.5M
↓ 76.01%
Q2 FY23Q/Q Change
Operating Cash Flow
$-12.4M
↓ 4.27%
Investing Cash Flow
$-33.0K
↑ 0.0%
Financing Cash Flow
$18.4M
↑ 55.19%
Q3 FY23Q/Q Change
Operating Cash Flow
$-13.4M
↑ 8.12%
Investing Cash Flow
$-13.0K
↓ 60.61%
Financing Cash Flow
$21.6M
↑ 17.7%

T2 Biosystems Technicals Summary

Sell

Neutral

Buy

T2 Biosystems is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

T2 Biosystems Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
T2 Biosystems Inc
-21.15%
-91.53%
-92.79%
-99.98%
-99.99%
Idexx Laboratories, Inc.
-7.8%
-13.05%
-23.61%
-25.62%
49.5%
Agilent Technologies Inc.
-5.77%
8.19%
1.73%
-6.52%
55.48%
Thermo Fisher Scientific, Inc.
-0.97%
0.03%
-1.73%
-14.88%
61.41%
Danaher Corp.
-0.45%
-2.06%
-0.01%
-22.5%
48.94%
Iqvia Holdings Inc.
-4.38%
-7.35%
-11.9%
-23.26%
23.76%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
T2 Biosystems Inc
0.02
NA
0.0
0.0
-6.22
-0.9
NA
-6.91
Idexx Laboratories, Inc.
39.83
39.83
4.35
10.73
0.59
0.23
NA
19.72
Agilent Technologies Inc.
30.63
30.63
2.26
5.56
0.25
0.08
0.01
20.53
Thermo Fisher Scientific, Inc.
32.58
32.58
1.98
21.7
0.13
0.05
0.0
128.08
Danaher Corp.
43.31
43.31
3.07
7.5
0.08
0.04
0.0
71.03
Iqvia Holdings Inc.
25.94
25.94
1.03
11.11
0.22
0.05
NA
38.37
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
T2 Biosystems Inc
Sell
$10.5M
-99.99%
0.02
0.0%
Idexx Laboratories, Inc.
Buy
$33.9B
49.5%
39.83
22.53%
Agilent Technologies Inc.
Buy
$38.8B
55.48%
30.63
21.75%
Thermo Fisher Scientific, Inc.
Buy
$199.0B
61.41%
32.58
14.48%
Danaher Corp.
Buy
$165.8B
48.94%
43.31
16.39%
Iqvia Holdings Inc.
Buy
$35.8B
23.76%
25.94
9.17%

About T2 Biosystems

t2 biosystems is developing innovative diagnostic products to improve patient health. with two fda-cleared products targeting sepsis – the cause of one out of two hospital deaths - and a range of additional products in development, t2 biosystems is an emerging leader in the field of in vitro diagnostics. our initial development efforts target sepsis, hemostasis, bacteria and lyme disease, which are areas of significant unmet medical need. the company is utilizing its proprietary t2 magnetic resonance platform, or t2mr®, to develop a broad set of applications aimed at lowering mortality rates, improving patient outcomes and reducing the cost of healthcare by helping medical professionals make targeted treatment decisions earlier. at t2 biosystems, we know that our passion to advance the medical diagnostic landscape relies on our ability to attract and retain the very best people in the world – and to encourage them to flourish. we invite you to apply for one of our open positions at www
Organization
T2 Biosystems
Employees
113
CEO
Mr. John J. Sperzel III, B.Sc.
Industry
Health Technology

Management People of T2 Biosystems

NameTitle
Mr. John J. Sperzel III, B.Sc.
President, CEO & Chairman
Mr. John M. Sprague CPA
Chief Financial Officer
Mr. Michael Terrence Gibbs Esq.
Senior VP, General Counsel & Company Secretary
Ms. Kelley J. Morgan
Chief People Officer
Mr. Brett A. Giffin
Chief Commercial Officer
Dr. Roger Smith Ph.D.
Senior Vice President of Science Research & Development

Important FAQs about investing in T2 Biosystems from India :

What is T2 Biosystems share price today?

T2 Biosystems share price today stands at $0.41, Open: $0.42 ; Previous Close: $0.41 ; High: $0.42 ; Low: $0.40 ; 52 Week High: $6.95 ; 52 Week Low: $0.31. The stock opens at $0.42, after a previous close of $0.41. The stock reached a daily high of $0.42 and a low of $0.40, with a 52-week high of $6.95 and a 52-week low of $0.31.

Can Indians buy T2 Biosystems shares?

Yes, Indians can invest in the T2 Biosystems (TTOO) from India.

With INDmoney, you can buy T2 Biosystems at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy T2 Biosystems at zero transaction cost.

How can I buy T2 Biosystems shares from India?

It is very easy to buy T2 Biosystems from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of T2 Biosystems be purchased?

Yes, you can buy fractional shares of T2 Biosystems with INDmoney app.

What are the documents required to start investing in T2 Biosystems stocks?

To start investing in T2 Biosystems, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of T2 Biosystems

Today’s highest price of T2 Biosystems (TTOO) is $0.42.

Today’s lowest price of T2 Biosystems (TTOO) is $0.40.

What is today's market capitalisation of T2 Biosystems

Today's market capitalisation of T2 Biosystems TTOO is 10.5M

What is the 52 Week High and Low Range of T2 Biosystems

  • 52 Week High

    $6.95

  • 52 Week Low

    $0.31

What are the historical returns of T2 Biosystems?

  • 1 Month Returns

    -21.15%

  • 3 Months Returns

    -91.53%

  • 1 Year Returns

    -92.79%

  • 5 Years Returns

    -99.99%

Who is the Chief Executive Officer (CEO) of T2 Biosystems

Mr. John J. Sperzel III, B.Sc. is the current Chief Executive Officer (CEO) of T2 Biosystems.